Estudio clnico randomizado del efecto de la suplementacin alimenticia durante el embarazo con L-arginina y vitaminas antioxidantes en pre-eclampsia en poblacin de alto riesgo
Case Report A 7-year-old boy from the countryside of the state of Maranho, northeastern Brazil, was admitted to the PICU having had fever for 6 days, headache, vomiting, maculopapular rash, severe abdominal pain, conjunctival hyperemia, photophobia, raspberry tongue, hyperemia with lip desquamation, right cervical lymphadenomegaly, and edema
How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Cardiovasc Res 49 (4), 798807
This hormone plays a key role in managing blood sugar and controlling appetite
